Kabra Drugs Profile
Key Indicators
- Authorised Capital ₹ 20.00 Cr
- Paid Up Capital ₹ 10.08 Cr
- Company Age 35 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 1.99 Cr
About Kabra Drugs
Kabra Drugs Limited (KDL) is a Public Limited Indian Non-Government Company incorporated in India on 22 August 1989 and has a history of 35 years and eight months. Its registered office is in Indore, Madhya Pradesh, India.
It is listed on the Bombay Stock Exchange(BSE) under the ticker symbol 524322.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 20.00 Cr and a paid-up capital of Rs 10.08 Cr.
The company has closed loans amounting to ₹1.99 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Kabra Drugs Limited India are Bangalore Kumar as CFO and Monika Gattani as Company Secretary. Nanjappan Aravind, Anand Anitha, Kuniamuthur Anand, and Two other members serve as directors at the Company.
Company Details
- Location
Indore, Madhya Pradesh, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
L02423MP1989PLC005438
- Company No.
005438
- Stock Symbol
BSE : 524322
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
22 Aug 1989
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Listed
- ROC Code
Roc Gwalior
Industry
Pharma
Kabra Drugs Limited
Explore comprehensive data for Kabra Drugs Limited, including financials, compliance details, shareholding patterns, and litigation history.
Who are the key members and board of directors at Kabra Drugs?
Executive Team (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Nanjappan Aravind  | Managing Director | 14-Aug-2024 | Current |
| Bangalore Kumar | CFO | 29-Jan-2020 | Current |
| Monika Gattani | Company Secretary | 14-Jul-2022 | Current |
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Anand Anitha | Director | 14-Jul-2022 | Current |
| Kuniamuthur Anand | Director | 09-Jun-2022 | Current |
| Bangalore Kumar | Whole-Time Director and Cfo | 29-Jan-2020 | Current |
| Ananthkumar Shilpa | Director | 19-Feb-2020 | Current |
Financial Performance of Kabra Drugs.
Kabra Drugs Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Kabra Drugs?
In 2023, Kabra Drugs had a public holding of 100.01%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Patchala Spintex Private LimitedMonika Gattani is a mutual person
Drushya Entertainment Broadcast Streams LimitedKuniamuthur Anand is a mutual person
- Nexgen Animators Private Limited
Kuniamuthur Anand is a mutual person
Charges (Loans)
Open Charges
₹0
Satisfied Charges
₹1.99 Cr
Charges Breakdown by Lending Institutions
- Religare Finvest Limited : 1.51 Cr
- Bank Of India : 0.48 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 31 Dec 2014 | Religare Finvest Limited | ₹1.51 Cr | Satisfied |
| 13 Nov 2010 | Bank Of India | ₹4.80 M | Satisfied |
How Many Employees Work at Kabra Drugs?
Unlock and access historical data on people associated with Kabra Drugs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Kabra Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kabra Drugs's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Latest Updates, News, and FAQs on Kabra Drugs
Recent activity within the organization
- Annual General Meeting
Kabra Drugs Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
- Director Appointment
Nanjappan Aravind was appointed as a Managing Director was appointed as a Managing Director on 14 Aug 2024 & has been associated with this company since 8 months 12 days .
- Balance Sheet
Kabra Drugs Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Gwalior.
- Director Appointment
Anand Anitha was appointed as a Director was appointed as a Director on 14 Jul 2022 & has been associated with this company since 2 years 9 months .
- Director Appointment
Monika Nishant Gattani was appointed as a Company Secretary was appointed as a Company Secretary on 14 Jul 2022 & has been associated with this company since 2 years 9 months .
- Director Appointment
Kuniamuthur Nanjappan Anand was appointed as a Director was appointed as a Director on 09 Jun 2022 & has been associated with this company since 2 years 10 months .
Recent News, Updates & Announcement
Kabra Drugs: Outcome of board meeting.The Board has accepted resignation of Mr. Rajendra Kumar Bordia from the Board of the Company..
Frequently asked questions
What is the Incorporation or founding date of Kabra Drugs Limited?
Kabra Drugs Limited was incorporated on 22 Aug 1989.
What is authorized share capital and paid-up capital of Kabra Drugs Limited?
The authorized share capital of Kabra Drugs Limited is ₹ 20.00 Cr and paid-up capital is ₹ 10.08 Cr.
Who are the current board members & directors of Kabra Drugs Limited?
Currently 7 directors are associated with Kabra Drugs Limited.
- Nanjappan Aravind
- Anand Anitha
- Kuniamuthur Nanjappan Anand
- Bangalore Venkatakrishnappa Ananth Kumar
- Ananthkumar Shilpa
- Bangalore Venkatakrishnappa Ananth Kumar
- Monika Nishant Gattani
What is the registered address of Kabra Drugs Limited?
As per Ministry of Corporate Affairs (Mca), the registered address of Kabra Drugs Limited is 208 Swadesh Bhavan 2 Press Complex, Ab Road India, Indore, Madhya Pradesh, 452011.
What is the corporate identification number (CIN) and company number of Kabra Drugs Limited?
The corporate identification number (CIN) of Kabra Drugs Limited is L02423MP1989PLC005438 and the company number is 005438 as per Ministry of Corporate Affairs (MCA).
Is Kabra Drugs Limited registered with any stock exchange in India?
Yes, Kabra Drugs Limited is registered on Bombay Stock Exchange (BSE).
What is the official website of Kabra Drugs Limited?
The Official website of Kabra Drugs Limited is https://www.kabradrugs.com
When was the last Balance Sheet of Kabra Drugs Limited filed with the ROC?
The most recent Balance Sheet for Kabra Drugs Limited was filed with the ROC on 31 Mar 2024.
Unlock Business Insights – Explore Instantly!
Search company & director profiles for free and gain access to critical business data.
- 3.1M+ Companies
- 15M+ Legal Cases
- 525K+ Credit Ratings
- 5.8M+ Directors & KMP
- 750K+ Regulatory Alerts
- 1.1M+ Companies' Financial Records
People also Viewed
RB
Rajendra BordiaDirectorKK
Kusum KabraWholetime DirectorSG
Snehlata GadiyaDirectorMS
Madhusudan SharmaDirectorMM
Mahendra MandloiWholetime DirectorRM
Ramachandran MuralidharanDirectorSB
Shashikant BapatDirectorCJ
Churchil JebastineDirector
Similar Companies Based on Drug Formulation & Development
Mylan Laboratories Limited Hyderabad, Telangana, India
Sun Pharma Laboratories Limited Vadodara, Gujarat, India
Sun Pharmaceutical Industries Limited Vadodara, Gujarat, India
Lupin Limited Mumbai, Maharashtra, India
Alkem Laboratories Limited Mumbai, Maharashtra, India
Hetero Labs Limited Rangareddy, Telangana, India
Aurobindo Pharma Ltd Hyderabad, Telangana, India
Cipla Limited Mumbai, Maharashtra, India